Epilepsy development in infancy with epileptic discharges. 2007

Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
Department of Child Neurology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Japan. magenta@md.okayama-u.ac.jp

As a part of the study to prevent West syndrome (WS) by early treatment, we assessed what kind of epilepsy developed in infants who showed epileptic discharges in early infancy. EEG examinations were performed on 116 infants born from 1997 to September 2004, both before and after 3 months of corrected age (CA). We divided 45 infants who showed epileptic discharges in early infancy into two groups according to the existence of periventricular leukomalacia (PVL) and retrospectively performed the course observation at the survey point on April 1 in 2005. Out of 45 infants showing epileptic discharges in early infancy, 26 developed WS. Compared with infants without PVL, infants with PVL were more likely to develop WS than infants without PVL. Furthermore, infants with PVL were more likely to develop WS than other types of epilepsy. Namely, 11 out of 17 infants with PVL developed WS at the survey point. All infants with WS showed initial epileptic discharges before 5 months of corrected age (CA), and most of them (except for five) had initial epileptic discharges before 3 months of CA. There were two infants who once developed hypsarrhythmia on EEG; however, after starting VPA therapy, they did not develop WS with the improvement of EEG findings, and one was presented here in detail. We proposed that preterm infants with PVL who showed epileptic discharges before 3 months of CA should be treated by antiepileptic drugs to prevent the onset of WS syndrome.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007969 Leukomalacia, Periventricular Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1) Cystic Periventricular Leukomalacia,Encephalomalacia, Periventricular,Neonatal Cerebral Leukomalacia,Periventricular Leukomalacia,Leucomalacia, Periventricular,Cerebral Leukomalacia, Neonatal,Cerebral Leukomalacias, Neonatal,Cystic Periventricular Leukomalacias,Encephalomalacias, Periventricular,Leucomalacias, Periventricular,Leukomalacia, Cystic Periventricular,Leukomalacia, Neonatal Cerebral,Leukomalacias, Cystic Periventricular,Leukomalacias, Neonatal Cerebral,Leukomalacias, Periventricular,Neonatal Cerebral Leukomalacias,Periventricular Encephalomalacia,Periventricular Encephalomalacias,Periventricular Leucomalacia,Periventricular Leucomalacias,Periventricular Leukomalacia, Cystic,Periventricular Leukomalacias,Periventricular Leukomalacias, Cystic
D008297 Male Males
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
September 2023, Clinical EEG and neuroscience,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
October 2005, Neuromodulation : journal of the International Neuromodulation Society,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
November 2009, Epilepsia,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
October 2013, Brain topography,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
October 2012, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
January 1992, Epilepsy research. Supplement,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
June 1956, Revue neurologique,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
January 2015, Journal of pediatric neurosciences,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
November 1975, Electroencephalography and clinical neurophysiology,
Harumi Yoshinaga, and Fumika Endo, and Kennichi Kikumoto, and Takushi Inoue, and Makio Oka, and Yoko Ohtsuka
January 2021, Iranian journal of child neurology,
Copied contents to your clipboard!